|
US715368A
(en)
|
1902-05-29 |
1902-12-09 |
Isaac N Graham |
Cutter-bar for harvesters or mowers.
|
|
US4215051A
(en)
|
1979-08-29 |
1980-07-29 |
Standard Oil Company (Indiana) |
Formation, purification and recovery of phthalic anhydride
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
EP0626012B1
(en)
|
1992-02-11 |
2003-07-09 |
Cell Genesys, Inc. |
Homogenotization of gene-targeting events
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
IT1263831B
(it)
|
1993-01-29 |
1996-09-04 |
Paolo Chiesi |
Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
|
|
SE502408C2
(sv)
|
1993-09-30 |
1995-10-16 |
Dataliner Ab |
Skalmönster vid lägesbestämning med hjälp av en snäv mätstråle
|
|
US5888767A
(en)
|
1996-11-27 |
1999-03-30 |
The Johns Hopkins University School Of Medicine |
Method of using a conditionally replicating viral vector to express a gene
|
|
OA11901A
(en)
|
1998-03-11 |
2006-04-10 |
Searle & Co |
Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
US7024312B1
(en)
|
1999-01-19 |
2006-04-04 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US6703491B1
(en)
*
|
1999-03-17 |
2004-03-09 |
Exelixis, Inc. |
Drosophila sequences
|
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
WO2001052843A1
(en)
|
2000-01-18 |
2001-07-26 |
Mcgill University |
β-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS
|
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
|
US7252952B2
(en)
|
2000-03-06 |
2007-08-07 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein—protein interaction
|
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
|
ATE409047T1
(de)
|
2001-04-30 |
2008-10-15 |
Lilly Co Eli |
Humanisierte antikörper
|
|
KR100566911B1
(ko)
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US7084257B2
(en)
*
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
ES2283759T3
(es)
|
2002-01-18 |
2007-11-01 |
Pierre Fabre Medicament |
Anticuerpos anti-igf-ir y sus aplicaciones.
|
|
US7153685B2
(en)
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
|
CA2526950C
(en)
*
|
2002-05-27 |
2012-06-26 |
Leif Hakansson |
Method for determining immune system affecting compounds
|
|
EP1513879B1
(en)
|
2002-06-03 |
2018-08-22 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
JP4596916B2
(ja)
*
|
2002-09-05 |
2010-12-15 |
メディミューン，エルエルシー |
Ｃｄ２拮抗薬を投与することによりｔ細胞悪性腫瘍を予防または治療する方法
|
|
US20090183270A1
(en)
*
|
2002-10-02 |
2009-07-16 |
Adams Thomas R |
Transgenic plants with enhanced agronomic traits
|
|
US20040208921A1
(en)
|
2003-01-14 |
2004-10-21 |
Ho Rodney J. Y. |
Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues
|
|
WO2004081186A2
(en)
|
2003-03-10 |
2004-09-23 |
Applera Corporation |
Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
|
|
CA2520846C
(en)
|
2003-03-31 |
2013-09-24 |
Mcmaster University |
Aptamer selection method
|
|
AU2003902875A0
(en)
*
|
2003-06-10 |
2003-06-26 |
The University Of Melbourne |
Immunomodulating compositions, uses therefor and processes for their production
|
|
MXPA05014155A
(es)
|
2003-06-27 |
2006-05-25 |
Abgenix Inc |
Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
|
|
BRPI0406605B8
(pt)
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
US8012468B2
(en)
|
2004-06-11 |
2011-09-06 |
Catholic Universtiy Industry Academic Cooperation Foundation |
Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same
|
|
FR2873699B1
(fr)
*
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
SE0402536D0
(sv)
|
2004-10-20 |
2004-10-20 |
Therim Diagnostica Ab |
Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
|
|
WO2006110091A1
(en)
|
2005-04-15 |
2006-10-19 |
Therim Diagnostica Ab |
Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
|
|
HRP20110404T1
(hr)
|
2005-11-08 |
2011-08-31 |
Ambrx |
Ubrzivači za modifikaciju ne-prirodnih aminokiselina i polipeptida ne-prirodnih aminokiselina
|
|
KR101423898B1
(ko)
|
2005-12-14 |
2014-07-28 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
|
|
US7812133B2
(en)
*
|
2005-12-16 |
2010-10-12 |
Genentech, Inc |
Anti-OX40L antibodies and methods using same
|
|
US7816324B2
(en)
|
2007-03-13 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Composition and method for the treatment of diseases affected by a peptide receptor
|
|
DK3130602T3
(da)
*
|
2007-05-08 |
2019-11-04 |
Canimguide Therapeutics Ab |
Immunregulerende strukturer fra normalt forekommende proteiner
|
|
WO2009047360A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Novo Nordisk A/S |
Il-21 antibodies
|
|
RU2360924C1
(ru)
*
|
2007-12-21 |
2009-07-10 |
Институт биохимии им. А.А. Баха РАН |
Маркер рака предстательной железы
|
|
WO2011119484A1
(en)
*
|
2010-03-23 |
2011-09-29 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
CA2838053A1
(en)
*
|
2011-06-03 |
2012-12-06 |
University Of South Alabama |
Methods and compositions for detecting endometrial or ovarian cancer
|
|
DK3043810T3
(da)
|
2013-09-09 |
2020-01-27 |
Canimguide Therapeutics Ab |
Immunsystemsmodulatorer
|
|
WO2016144650A1
(en)
|
2015-03-06 |
2016-09-15 |
Canimguide Therapeutics Ab |
Immune system modulators and compositions
|